Anavip Injection, Powder, Lyophilized, For Solution
Product Images NDC 66621-0790

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Anavip (NDC 66621-0790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rare Disease Therapeutics, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Anavip Carton Label (Anavip Carton Label)

ANAVIP® is a crotalidae immune F(ab') medicine that comes in a single-dose vial. The product is indicated for intravenous use only, and the package must be reconstituted with 10 mL of 0.9% Sodium Chloride USP and then further diluted in 250 mL of 0.9% Sodium Chloride USP. The reconstituted and diluted product must be used within 6 hours. Each vial contains no more than 120mg/ml total protein and not less than the indicated number of mouse LD50 neutralizing units per vial. The medication can be used for various venomous snakes' bites. Dosage information and storage instructions are included in the product packaging.*

FDA Label Image

Anavip Serialized Carton Example

FDA Label Image

Anavip Vial Label (Anavip Vial Label)

ANAVIP is a medicine produced by Laboratorios Silanes, S.A. de C.V. It is a sterile and nonpyrogenic lyophilized single-dose vial used for intravenous purposes. It contains crotalidae immune F(ab’), (equine), and has no preservatives. ANAVIP is not recommended to be stored at temperatures below room temperature, and dosage information can be found in the package insert. The text contains information about its packaging, including its dimensions, type of material, and special finishes. There is no information about its indications or therapeutic uses.*

FDA Label Image

Rdt Logo

This is a company name: Rare Disease Therapeutics, Inc. It indicates that the company is likely focused on developing treatments for rare diseases.*

FDA Label Image

Silanes Logo

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.